# Phase 4 Atrial Fibrillation trials recruiting: 49 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 49 trials in phase 4 for Atrial Fibrillation that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Atrial Fibrillation trials: 49 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/atrial-fibrillation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 49
- Recruiting or not yet: 49
- Read on: November 19, 2026

## Trials

The 25 newest of 49, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 2, 2026 | NCT07910058 | Sacubitril/Valsartan vs Standard Treatment for Preventing Atrial Fibrillation Recurrence After Catheter Ablation in Persistent Atrial... | Ruijin Hospital | Phase 4 | Not yet recruiting | Atrial Fibrillation (Persistent), Catheter Ablation, Non-hypertension, Angiotensin Receptor/Neprilysin Inhibitor | 472 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910058) |
| October 29, 2026 | NCT07904507 | A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation | University Hospital, Basel, Switzerland | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF) | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904507) |
| October 16, 2026 | NCT07877116 | Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Persistent Atrial Fibrillation | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877116) |
| August 20, 2026 | NCT07776054 | Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF | Samsung Medical Center | Phase 4 | Recruiting | Atrial Fibrillation, SGLT2 Inhibitor, DC Cardioversion | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776054) |
| August 7, 2026 | NCT07753200 | Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease | Samsung Medical Center | Phase 4 | Recruiting | Atrial Fibrillation (AF), Coronary Arterial Disease (CAD) | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753200) |
| August 7, 2026 | NCT07752758 | Ezetimibe for Arrhythmia Recurrence After AF Ablation | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | Atrial Fibrillation, Post-Catheter Ablation Atrial Arrhythmia Recurrence | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752758) |
| July 21, 2026 | NCT07715929 | Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Atrial Fibrillation, Obesity & Overweight, Catheter Ablation | 710 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715929) |
| July 15, 2026 | NCT07706075 | Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation) | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF), Atrial Fibrillation With Rapid Ventricular Response | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706075) |
| June 5, 2026 | NCT07630454 | Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction (HFpEF), Tirzepatide | 602 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630454) |
| May 27, 2026 | NCT07609654 | Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | Intracerebral Hemorrhage, Atrial Fibrillation (AF), Ischemia Stroke | 852 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609654) |
| May 6, 2026 | NCT07571447 | Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided... | Gødstrup Hospital | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF), Atrial Flutter | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571447) |
| May 6, 2026 | NCT07570940 | A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass... | Mayo Clinic | Phase 4 | Not yet recruiting | Coronary Artery Disease, Atrial Fibrillation | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570940) |
| April 2, 2026 | NCT07508618 | Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule | Sir Run Run Shaw Hospital | Phase 4 | Recruiting | Persistent Atrial Fibrillation | 846 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07508618) |
| March 27, 2026 | NCT07496281 | OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation | Ewha Womans University Mokdong Hospital | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496281) |
| March 3, 2026 | NCT07445789 | SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation | Martini Hospital Groningen | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF) | 436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445789) |
| February 12, 2026 | NCT07405671 | Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation | Universitaire Ziekenhuizen KU Leuven | Phase 4 | Recruiting | Atrial Fibrillation (AF), Coronary Artery Disease | 988 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405671) |
| February 5, 2026 | NCT07389941 | Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation | University of Luebeck | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF) | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07389941) |
| December 10, 2025 | NCT07275697 | Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study | Sponsor not shown (see the record) | Phase 4 | Recruiting | Atrial Fibrillation (AF), Obesity & Overweight | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07275697) |
| December 10, 2025 | NCT07273994 | Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion... | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Phase 4 | Recruiting | Persistent Atrial Fibrillation | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07273994) |
| December 8, 2025 | NCT07270848 | Dronedarone Rhythm Intervention for Early Atrial Fibrillation | Inha University Hospital | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF) | 1,898 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270848) |
| November 19, 2025 | NCT07237308 | BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis | Yonsei University | Phase 4 | Recruiting | Stroke, Ischemic, Atrial Fibrillation, Arteriosclerosis, Intracranial Arteriosclerosis | 586 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07237308) |
| September 15, 2025 | NCT07173855 | Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients | Scarborough General Hospital | Phase 4 | Recruiting | Critical Illness | 3,853 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07173855) |
| August 22, 2025 | NCT07135258 | Atrial Fibrillation: In Search for the Optimal Target for Rate Control | The University of Hong Kong | Phase 4 | Not yet recruiting | Atrial Fibrillation (Permanent), Atrial Fibrillation (AF) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07135258) |
| June 19, 2025 | NCT07027969 | Metabolic Surgery for Atrial Fibrillation Elimination | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Atrial Fibrillation, Obesity and Obesity-related Medical Conditions | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07027969) |
| May 1, 2025 | NCT06953726 | Comparing the Safety and Efficacy of Apixaban and Rivaroxaban | VA Office of Research and Development | Phase 4 | Recruiting | Atrial Fibrillation | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06953726) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Samsung Medical Center | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Yonsei University | 2 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| University Hospital, Bordeaux | 1 |
| Odense University Hospital | 1 |
| VA Office of Research and Development | 1 |
| University of Luebeck | 1 |
| Charite University, Berlin, Germany | 1 |
| Medical University of Silesia | 1 |
| Hospital Sirio-Libanes | 1 |
| Medical University of Gdansk | 1 |
| St. Antonius Hospital | 1 |
| Sir Run Run Shaw Hospital | 1 |
| Ruijin Hospital | 1 |
| Scarborough General Hospital | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Inha University Hospital | 1 |
| Ottawa Hospital Research Institute | 1 |
| Ewha Womans University Mokdong Hospital | 1 |
| Indiana University | 1 |
| Korea University Anam Hospital | 1 |
| University of Chicago | 1 |

## By country

| Country | Trials |
| --- | --- |
| South Korea | 8 |
| United States | 7 |
| China | 4 |
| Poland | 4 |
| Spain | 4 |
| Denmark | 4 |
| Belgium | 3 |
| France | 3 |
| Germany | 3 |
| Netherlands | 3 |
| Switzerland | 3 |
| United Kingdom | 3 |
| Canada | 3 |
| Sweden | 2 |
| Italy | 2 |
| Brazil | 2 |
| Turkey (Türkiye) | 1 |
| Argentina | 1 |
| Australia | 1 |
| Finland | 1 |
| India | 1 |
| Nepal | 1 |
| Pakistan | 1 |
| Hong Kong | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
- [Meat wholesalers in the United States](https://specstream.ai/data/businesses/meat-wholesalers/united-states)
- [Moroccan restaurants in the United States](https://specstream.ai/data/businesses/moroccan-restaurants/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Pediatric dentistry practices in the United States](https://specstream.ai/data/businesses/pediatric-dentistry-practices/united-states)
- [Podiatrists in the United States](https://specstream.ai/data/businesses/podiatrists/united-states)
